PCN35 ECONOMIC EVALUATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) CHEMOTHERAPY REGIME WITH OR WITHOUT RITUXIMAB (R) IN THE 2ND LINE TREATMENT OF FOLLICULAR NON-HODGIN LYMPHOMA
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66572-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)66572-2/fulltext
Title :
PCN35 ECONOMIC EVALUATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) CHEMOTHERAPY REGIME WITH OR WITHOUT RITUXIMAB (R) IN THE 2ND LINE TREATMENT OF FOLLICULAR NON-HODGIN LYMPHOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66572-2&doi=10.1016/S1098-3015(10)66572-2
First page :
Section Title :
Open access? :
No
Section Order :
407